vs

Side-by-side financial comparison of American Well Corp (AMWL) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Health Catalyst, Inc. is the larger business by last-quarter revenue ($74.7M vs $55.3M, roughly 1.4× American Well Corp). American Well Corp runs the higher net margin — -45.1% vs -121.9%, a 76.8% gap on every dollar of revenue. On growth, Health Catalyst, Inc. posted the faster year-over-year revenue change (-6.2% vs -22.1%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $-17.4M). Over the past eight quarters, Health Catalyst, Inc.'s revenue compounded faster (-0.0% CAGR vs -3.6%).

The American Tobacco Company was a tobacco company founded in 1890 by J. B. Duke through a merger between a number of U.S. tobacco manufacturers including Allen and Ginter, Goodwin & Company, and Kinney Brothers. The company was one of the original 12 members of the Dow Jones Industrial Average in 1896. The American Tobacco Company dominated the industry by acquiring the Lucky Strike Company and over 200 other rival firms. Federal Antitrust action begun in 1907 broke the company into several ...

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

AMWL vs HCAT — Head-to-Head

Bigger by revenue
HCAT
HCAT
1.4× larger
HCAT
$74.7M
$55.3M
AMWL
Growing faster (revenue YoY)
HCAT
HCAT
+15.9% gap
HCAT
-6.2%
-22.1%
AMWL
Higher net margin
AMWL
AMWL
76.8% more per $
AMWL
-45.1%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$27.0M more FCF
HCAT
$9.6M
$-17.4M
AMWL
Faster 2-yr revenue CAGR
HCAT
HCAT
Annualised
HCAT
-0.0%
-3.6%
AMWL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMWL
AMWL
HCAT
HCAT
Revenue
$55.3M
$74.7M
Net Profit
$-24.9M
$-91.0M
Gross Margin
Operating Margin
-45.5%
-115.3%
Net Margin
-45.1%
-121.9%
Revenue YoY
-22.1%
-6.2%
Net Profit YoY
41.6%
-340.3%
EPS (diluted)
$-1.53
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMWL
AMWL
HCAT
HCAT
Q4 25
$55.3M
$74.7M
Q3 25
$56.3M
$76.3M
Q2 25
$70.9M
$80.7M
Q1 25
$66.8M
$79.4M
Q4 24
$71.0M
$79.6M
Q3 24
$61.0M
$76.4M
Q2 24
$62.8M
$75.9M
Q1 24
$59.5M
$74.7M
Net Profit
AMWL
AMWL
HCAT
HCAT
Q4 25
$-24.9M
$-91.0M
Q3 25
$-32.4M
$-22.2M
Q2 25
$-19.7M
$-41.0M
Q1 25
$-18.7M
$-23.7M
Q4 24
$-42.7M
$-20.7M
Q3 24
$-43.5M
$-14.7M
Q2 24
$-49.9M
$-13.5M
Q1 24
$-72.1M
$-20.6M
Gross Margin
AMWL
AMWL
HCAT
HCAT
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
AMWL
AMWL
HCAT
HCAT
Q4 25
-45.5%
-115.3%
Q3 25
-52.1%
-22.9%
Q2 25
-28.7%
-46.0%
Q1 25
-45.5%
-25.4%
Q4 24
-60.2%
-22.0%
Q3 24
-77.6%
-17.9%
Q2 24
-83.4%
-20.8%
Q1 24
-126.1%
-30.5%
Net Margin
AMWL
AMWL
HCAT
HCAT
Q4 25
-45.1%
-121.9%
Q3 25
-57.5%
-29.1%
Q2 25
-27.8%
-50.8%
Q1 25
-28.0%
-29.9%
Q4 24
-60.1%
-26.0%
Q3 24
-71.2%
-19.3%
Q2 24
-79.5%
-17.8%
Q1 24
-121.1%
-27.6%
EPS (diluted)
AMWL
AMWL
HCAT
HCAT
Q4 25
$-1.53
$-1.29
Q3 25
$-2.00
$-0.32
Q2 25
$-1.24
$-0.59
Q1 25
$-1.19
$-0.35
Q4 24
$-2.71
$-0.33
Q3 24
$-2.87
$-0.24
Q2 24
$-3.36
$-0.23
Q1 24
$-4.94
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMWL
AMWL
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$182.3M
$95.7M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$235.6M
$245.8M
Total Assets
$323.8M
$502.6M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMWL
AMWL
HCAT
HCAT
Q4 25
$182.3M
$95.7M
Q3 25
$200.9M
$91.5M
Q2 25
$219.1M
$97.3M
Q1 25
$222.4M
$342.0M
Q4 24
$228.3M
$392.0M
Q3 24
$244.6M
$387.3M
Q2 24
$276.9M
$308.3M
Q1 24
$308.6M
$327.8M
Total Debt
AMWL
AMWL
HCAT
HCAT
Q4 25
$153.3M
Q3 25
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
AMWL
AMWL
HCAT
HCAT
Q4 25
$235.6M
$245.8M
Q3 25
$254.9M
$331.9M
Q2 25
$282.6M
$347.5M
Q1 25
$294.0M
$376.8M
Q4 24
$304.8M
$365.2M
Q3 24
$336.7M
$355.0M
Q2 24
$363.9M
$357.0M
Q1 24
$408.7M
$357.2M
Total Assets
AMWL
AMWL
HCAT
HCAT
Q4 25
$323.8M
$502.6M
Q3 25
$359.4M
$587.1M
Q2 25
$388.7M
$616.2M
Q1 25
$419.5M
$891.5M
Q4 24
$436.0M
$858.9M
Q3 24
$483.0M
$813.0M
Q2 24
$507.8M
$691.7M
Q1 24
$548.4M
$695.1M
Debt / Equity
AMWL
AMWL
HCAT
HCAT
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMWL
AMWL
HCAT
HCAT
Operating Cash FlowLast quarter
$-17.4M
$9.9M
Free Cash FlowOCF − Capex
$-17.4M
$9.6M
FCF MarginFCF / Revenue
-31.4%
12.9%
Capex IntensityCapex / Revenue
0.0%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMWL
AMWL
HCAT
HCAT
Q4 25
$-17.4M
$9.9M
Q3 25
$-18.8M
$-464.0K
Q2 25
$-4.7M
$-9.0M
Q1 25
$-25.1M
$280.0K
Q4 24
$-13.4M
$-3.5M
Q3 24
$-32.4M
$6.2M
Q2 24
$-21.8M
$1.6M
Q1 24
$-59.8M
$10.3M
Free Cash Flow
AMWL
AMWL
HCAT
HCAT
Q4 25
$-17.4M
$9.6M
Q3 25
$-719.0K
Q2 25
$-9.2M
Q1 25
$-25.1M
$-390.0K
Q4 24
$-13.4M
$-3.9M
Q3 24
$-32.4M
$5.5M
Q2 24
$-21.8M
$1.3M
Q1 24
$-59.8M
$10.1M
FCF Margin
AMWL
AMWL
HCAT
HCAT
Q4 25
-31.4%
12.9%
Q3 25
-0.9%
Q2 25
-11.4%
Q1 25
-37.6%
-0.5%
Q4 24
-18.9%
-4.9%
Q3 24
-53.0%
7.2%
Q2 24
-34.7%
1.7%
Q1 24
-100.5%
13.5%
Capex Intensity
AMWL
AMWL
HCAT
HCAT
Q4 25
0.0%
0.4%
Q3 25
0.0%
0.3%
Q2 25
0.0%
0.3%
Q1 25
0.0%
0.8%
Q4 24
0.0%
0.5%
Q3 24
0.0%
0.9%
Q2 24
0.0%
0.4%
Q1 24
0.1%
0.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMWL
AMWL

Platform Subscription$28.8M52%
Visits$23.7M43%
Others$2.8M5%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons